March 7, 2023 — Ninety-five percent of athletes with a diagnosed and treated genetic heart disease experienced no ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
March 7, 2023 — A virtual care team-guided strategy for guideline-directed medical therapy (GDMT) optimization was found ...
March 5, 2023 — Researchers demonstrated that a causal artificial intelligence (AI) system can accurately quantify how ...
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
March 5, 2023 — Doctors who received customized electronic health record (EHR) alerts for specific patients were 2.5 ...
March 4, 2023 - Lexicon Pharmaceuticals, Inc. Â announced new analyses of results from the SOLOIST-WHF Phase 3 outcomes ...
March 4, 2023 — GE HealthCare will present its latest technologies and innovations for use during the critical planning ...
March 3, 2023 —  Researchers may be able to predict cardiovascular disease – such as atrial fibrillation and heart ...
February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being ...
March 1, 2023 — Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, today ...
February 27, 2023 — CÚRAM SFI Research Centre for Medical Devices researchers have published in Nature Communications a ...
February 24, 2023 —  Abiomed, Inc., part of Johnson & Johnson MedTech[1], announced that results from a study on Impella ...
February 23, 2023 — Lexicon Pharmaceuticals, Inc. announced the upcoming presentation of new analyses of results from ...
February 22, 2023 — CVRx, Inc., a commercial-stage medical device company focused on developing, manufacturing and ...
February 21, 2023 — Strokes are a leading cause of morbidity and mortality in the United States, as well as around the ...
February 20, 2023 — Esperion announced that the landmark Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting ...